ProShare Advisors
NUTX

ProShare Advisors’s Nutex Health NUTX Stock Holding History

ProShare Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-199
Closed -$30.1K – 1891
2023
Q1 		$30.1K Sell
199
-16
-7% -$3.24K ﹤0.01% 1713
2022
Q4 		$61.3K Buy
+215
New +$41.3K ﹤0.01% 1719

Other funds holding NUTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BHWM
Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

ProShare Advisors's NUTX Position: Q2 2023 in Review

ProShare Advisors sold out of Nutex Health (NUTX) in Q2 2023, closing a stake of 199 shares — an estimated $30.1K sold.

ProShare Advisors first reported a position in NUTX in Q4 2022 and held it in 2 quarters. The position peaked at $61.3K in Q4 2022. 74 funds tracked by Wall St. Rank hold NUTX as of Q2 2023.

  • ProShare Advisors reported no remaining Nutex Health position as of Q2 2023 after selling out during the quarter.
  • ProShare Advisors sold 199 Nutex Health shares in Q2 2023, an estimated $30.1K.
  • ProShare Advisors first reported a position in Nutex Health in Q4 2022 and held it in 2 quarters.
  • ProShare Advisors's Nutex Health position peaked at $61.3K in Q4 2022.
  • 74 funds tracked by Wall St. Rank held Nutex Health as of Q2 2023.

Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.